These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

19 related articles for article (PubMed ID: 6950086)

  • 1. Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.
    Sharif NA; Klimko PG
    Br J Pharmacol; 2019 Apr; 176(8):1059-1078. PubMed ID: 29679483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoid receptor antagonists: development strategies and therapeutic applications.
    Jones RL; Giembycz MA; Woodward DF
    Br J Pharmacol; 2009 Sep; 158(1):104-45. PubMed ID: 19624532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogenic increase in PGE2 and PGF2 alpha receptor density in brain microvessels of pigs.
    Li DY; Varma DR; Chemtob S
    Br J Pharmacol; 1994 May; 112(1):59-64. PubMed ID: 8032662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the pulmonary vasoconstrictor response to prostaglandin F2alpha by N-dimethylamino substitution of prostaglandin F2alpha.
    Fitzpatrick TM; Alter I; Corey EJ; Ramwell PW; Rose JC; Kot PA
    J Pharmacol Exp Ther; 1978 Jul; 206(1):139-42. PubMed ID: 660543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of central and peripheral action of F2 alpha prostaglandin on the circulation of rat and guinea pig.
    Brus R; Herman ZS; Zabawska J
    Acta Med Pol; 1981; 22(3):193-7. PubMed ID: 6958178
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular research on PGI2, 6-keto-PGF1 alpha, PGF2 alpha, and 15(S)-15-methyl-PGF2 alpha.
    Marmo E; Rossi F; Lampa E; Giordano L; Caputi AP; Vacca C; Ariello B; Rosatti F
    Adv Prostaglandin Thromboxane Res; 1980; 7():701-9. PubMed ID: 6989197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Radiomodifying properties of the synthetic analog of prostaglandin F2 alpha-estrofan].
    Chernov IuN; Vasin MV; Semenova LA
    Radiobiologiia; 1988; 28(4):530-2. PubMed ID: 3166523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of blockade of M-cholinoreactive structures on the hemodynamics effects of prostaglandin F2 alpha].
    Abaskulieva LI; Khanumova TA
    Fiziol Zh SSSR Im I M Sechenova; 1986 Feb; 72(2):207-13. PubMed ID: 3457718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective antagonism of prostaglandin F2 alpha-mediated vascular responses by N-dimethylamino substitution of prostaglandin F2 alpha.
    Stinger RB; Fitzpatrick TM; Corey EJ; Ramwell PW; Rose JC; Kot PA
    J Pharmacol Exp Ther; 1982 Mar; 220(3):521-5. PubMed ID: 6950086
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular pharmacology of buflomedil.
    Vanhoutte PM
    Bibl Cardiol; 1984; (38):209-21. PubMed ID: 6398070
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.